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Tissue-Type-Plasminogen-Activator-Associated Fibrinolysis in Orthotopic 
Liver Transplantation 
R.J. Porte, FA Bontempo, EAR. Knot, J.H. Lewis, Y.G. Kang, and T.E. Starzl 
ORTHOTOPIC liver transplantation is frequently asso-
ciated with hemostatic disorders and a bleeding diath-
esis.I.2 Accelerated fibrinolysis has been recognized as an 
important component of the hemostatic defectY The origin 
of this fibrinolytic activity, however, is still unclear. We 
investigated the role of tissue-type plasminogen activator 
(tPA). a potent activator of the fibrinolytic system, in the 
origin of increased fibrinolytic activity during orthotopic 
liver transplantation. 
MATERIALS AND METHODS 
Arterial blood samples were taken at regular intervals during 20 
consecutive, first-time orthotopic liver transplantations in adults. 
Fibrinolysis was measured by euglobulin lysis time (ELT; normal 
> 120 minutes) and whole blood clot lysis time, as determined by 
thromboelastography (normal >150 minutes). tPA activity was 
measured in acidified plasma (pH 4.0-4.1) using Coaset tPA/PAI 
(Kabi Vitrum, Stockholm, Sweden) (normal: 0-1 IV/mL). 
RESULTS 
In all but one patient moderate to severe fibrinolysis, as 
measured by shortening of EL T or whole blood clot lysis 
time, was found in at least one blood sample during surgery. 
Intraoperative levels of tPA activity are shown in Fig 1. An 
intraoperative increase of tPA activity was found in 18 of the 
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Fig 1. Tissue-type plasminogen activator activity during 
liver transplantation (n - 20). Blood samples were taken after 
Induction of anesthesia, 30 minutes before the anhepatlc 
stage, 10 minutes into the anhepatlc stage, 5 minutes before 
reperfuslon, 5 minutes, 30 minutes, 90 minutes, and 180 
minutes after reperfusion, and at the end of the procedure. 
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20 patients. Comparison of the tPA activity levels and the 
corresponding values of the EL T showed that an increase of 
tPA activity to about \0 IU/mL resulted in a rapid short-
ening of the EL T, while a further increase had no additional 
effect. A more linear relation was found between tPA 
activity and the whole blood clot lysis time. 
DISCUSSION 
It was demonstrated that orthotopic liver transplantation is 
associated with a high increase of plasma levels of tPA 
activity. A combination of increased release and reduced 
hepatic clearance may explain the initial increase during the 
anhepatic stage. This view is supported by the lack of 
fibrinolysis activation during auxiliary liver transplantation.) 
An "explosive" increase in tPA activity occurred immedi-
ately after reperfusion. This is in agreement with the clinical 
findings of generalized oozing and increased blood loss 
during this period,2 and suggests a release of tPA from the 
donor liver. In a recent small study, increased plasma levels 
of tPA occurred primarily during the an hepatic stage of 
orthotopic liver transplantation.4 Since we observed an 
extreme increase in tPA activity only during a short period 
after reperfusion, this peak could have been missed if no 
blood samples were taken within 10 minutes after reperfu-
sion. Although the systemic increase in tPA activity is 
transient, the clinical effect may extend over a considerably 
longer period, as tPA may bind to fibrin and become 
incorporated in newly formed hemostatic clots, resulting in 
early lysis and insufficient hemostatic function. 
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